Compare UPXI & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UPXI | OKYO |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 101.2M | 83.4M |
| IPO Year | 2021 | 2021 |
| Metric | UPXI | OKYO |
|---|---|---|
| Price | $1.36 | $1.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $2.00 | ★ $6.33 |
| AVG Volume (30 Days) | ★ 3.0M | 83.3K |
| Earning Date | 05-15-2026 | 07-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.49 | N/A |
| EPS | ★ 0.76 | N/A |
| Revenue | ★ $15,811,345.00 | N/A |
| Revenue This Year | $118.99 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.84 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.54 | $1.31 |
| 52 Week High | $16.00 | $3.35 |
| Indicator | UPXI | OKYO |
|---|---|---|
| Relative Strength Index (RSI) | 58.14 | 47.06 |
| Support Level | $0.91 | $1.50 |
| Resistance Level | $2.46 | $1.73 |
| Average True Range (ATR) | 0.11 | 0.12 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 68.35 | 45.83 |
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via Solana. Geographically, the company generates the majority of its revenue from the United States.
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.